Skip to main content
. 2021 Mar 24;2021(3):CD013705. doi: 10.1002/14651858.CD013705.pub2

Smithgall 2020 [A].

Study characteristics
Patient Sampling Two‐group study to estimate sensitivity and specificity:
‐ patients undergoing routine clinical testing by RT‐PCR (n = 113)
Recruitment: unclear; describes deliberate sampling of samples with high, medium and low Ct values on the reference standard RT‐PCR
Prospective or retrospective: unclear; residual swabs used but testing undertaken within 48 h of sample collection
Number of samples (samples with confirmed SARS‐CoV‐2): 113 (88)
Patient characteristics and setting Setting: inpatient and ED (n from each not reported)
Location: not stated; author institution is Columbia University Irving Medical Centre
Country: USA
Dates: 8‐13 April 2020
Symptoms and severity: not stated
Demographics: 111 adult (range 23‐101 years; average 65 years for RT‐PCR‐positive and 43 years for RT‐PCR‐negative); 2 paediatric (age 1 day and 5 days)
61, 54% male
Exposure history: not stated
Index tests Test name:
[A] ID NOW (see Smithgall 2020 [B] for details of comparator test)
(product codes not reported)
Manufacturer: [A] Abbott
Antigen target: [A] RdRp gene
Antibody: N/A
Test method: [A] isothermal PCR
Samples used: residual NP swabs (collection not described)
Transport media: 3 mL VTM (M4RT VTM; ThermoFisher Scientific, Waltham, MA) or UTM (UTM; Becton Dickinson and Co., Franklin Lakes, NJ)
Sample storage: stored at 4 °C; testing completed within 48 h of sample collection
Test operator: not stated; presume laboratory staff
Definition of test positivity: automated as per manufacturer
Blinding reported: not stated
Timing of samples: not stated; presume on admission or presentation at ED
Target condition and reference standard(s) Reference standard: RT‐PCR with cobas SARS‐CoV‐2 assay on the 6800 platform (Roche Diagnostics, Indianapolis, IN); threshold not stated, all Ct values < 37 on both target genes
Definition of non‐COVID cases: not stated; presume single RT‐PCR negative
Genetic target(s): ORF1 a/b, E‐gene
Samples used: as for index test
Timing of reference standard: as for index test
Blinded to index test: as for index test
Incorporated index test: no
Flow and timing Time interval between index and reference tests: simultaneous; same samples used
All participants received same reference standard: yes
Missing data: none reported
Uninterpretable results:
Indeterminate results (index test): Xpert: 1 sample was a presumptive positive based on detection of E‐gene target but not the N2 target
Indeterminate results (reference standard): none reported
Unit of analysis: participants
Comparative  
Notes Funding: none reported
Publication status: published
Source: Journal of Clinical Virology
Author COI: study authors report no conflicts of interest present
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? No    
Was a case‐control design avoided? No    
Did the study avoid inappropriate exclusions? Unclear    
Did the study avoid inappropriate inclusions? Unclear    
Could the selection of patients have introduced bias?   High risk  
Are there concerns that the included patients and setting do not match the review question?     High
DOMAIN 2: Index Test (Antigen tests)
DOMAIN 2: Index Test (Rapid molecular tests)
Were the index test results interpreted without knowledge of the results of the reference standard? Unclear    
If a threshold was used, was it pre‐specified? No    
Could the conduct or interpretation of the index test have introduced bias?   High risk  
Are there concerns that the index test, its conduct, or interpretation differ from the review question?     High
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? No    
Were the reference standard results interpreted without knowledge of the results of the index tests? Unclear    
Reference standard does not incorporate result of index test? Yes    
Could the reference standard, its conduct, or its interpretation have introduced bias?   High risk  
Are there concerns that the target condition as defined by the reference standard does not match the question?     High
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Yes    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? Unclear    
Did all participants receive a reference standard? Yes    
Were results presented per patient? Yes    
Could the patient flow have introduced bias?   Unclear risk